Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma
Trial ID or NCT#
Status
Purpose
This clinical trial compares and contrasts lymph node mapping using indocyanine green (IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC). Study participants with malignant melanoma will undergo all 3 evaluations to assess the extent of the spread of the melanoma.
Official Title
Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma
Eligibility Criteria
- - Ability to understand and willingness to sign informed consent document - Signed written informed consent - Malignant melanoma (MM) undergoing sentinel lymph node biopsy (SNLB) - 18 years of age or older - Complete blood count (CBC) and metabolic panel within 6 months
- - History of hepatic or renal failure - Allergy to iodine containing products - Pregnant or may be pregnant - Psychiatric or addictive disorders that in the opinion of the research team, may not be able to meet study requirements - Undergoing dialysis
Contact us to find out if this trial is right for you.
Contact
Ralph S. Greco
650-736-1355
View on ClinicalTrials.gov